Your browser doesn't support javascript.
loading
Safety, tolerability, and pharmacokinetics of anti-EGFRvIII antibody-drug conjugate AMG 595 in patients with recurrent malignant glioma expressing EGFRvIII.
Rosenthal, Mark; Curry, Richard; Reardon, David A; Rasmussen, Erik; Upreti, Vijay V; Damore, Michael A; Henary, Haby A; Hill, John S; Cloughesy, Timothy.
Afiliação
  • Rosenthal M; Department of Medical Oncology, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia. mark.rosenthal@petermac.org.
  • Curry R; TriHealth Physician Partners, Cincinnati, OH, USA.
  • Reardon DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Rasmussen E; Amgen Inc., Thousand Oaks, CA, USA.
  • Upreti VV; Clinical Pharmacology Modeling and Simulation, Amgen Inc., South San Francisco, CA, USA.
  • Damore MA; Amgen Inc., Thousand Oaks, CA, USA.
  • Henary HA; Amgen Inc., Thousand Oaks, CA, USA.
  • Hill JS; Department of Early Oncology Development and Clinical Research, Pfizer Inc., San Diego, CA, USA.
  • Cloughesy T; The Ronald Reagan UCLA Medical Center, Los Angeles, CA, USA.
Cancer Chemother Pharmacol ; 84(2): 327-336, 2019 08.
Article em En | MEDLINE | ID: mdl-31154523

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Imunoconjugados / Glioma / Maitansina Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Imunoconjugados / Glioma / Maitansina Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália